Braveheart Bio, Inc. Common Stock (BRVE) — Working Capital to Net Assets Ratio
Braveheart Bio, Inc. Common Stock (BRVE) has a Working Capital to Net Assets ratio of -90.7% as of March 2026. Working capital of $71.07 Million (current assets of $81.07 Million minus current liabilities of $10.00 Million) is measured against net assets of $-78.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see how large is Braveheart Bio, Inc. Common Stock's balance sheet.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Annual Working Capital to Net Assets for Braveheart Bio, Inc. Common Stock (None–None)
The table below presents the year-by-year Working Capital to Net Assets ratio for Braveheart Bio, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Braveheart Bio, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|